Global API sourcing simplified
We connect API buyers and suppliers worldwide with speed, trust, and full transparency.

Filters

Filters
Filter
Custom request?
Type
Production region
Qualifications
Show more
Country of origin
Show more

Menthol API Manufacturers & Suppliers

13 verified results
Take control of your API sourcing
Submit a Special Inquiry and have Pharmaoffer activate verified suppliers.

Commercial-scale Suppliers

Distributor
Produced in  India
|

Employees: 50+

|
Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested!
Certifications: GMP
|
USDMF
|
MSDS
|
BSE/TSE
|
CoA

All certificates

GMP
USDMF
MSDS
BSE/TSE
CoA
Distributor
Produced in  India
|

Employees: 50+

|
Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested!
Certifications: GMP
|
MSDS
|
ISO9001
|
CoA

All certificates

GMP
MSDS
ISO9001
CoA
Take control of your API sourcing
Submit a Special Inquiry and have Pharmaoffer activate verified suppliers.
Distributor
Produced in  France
|

Employees: 275+

|
Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested!
Certifications: GMP
|
MSDS
|
BSE/TSE
|
ISO9001
|
CoA

All certificates

GMP
MSDS
BSE/TSE
ISO9001
CoA
Distributor
Produced in  United States
|

Employees: 50+

|
Audit Report: Click here for more information on Eurofins audit reports
Certifications: GMP
|
MSDS
|
BSE/TSE
|
ISO9001
|
CoA

All certificates

GMP
MSDS
BSE/TSE
ISO9001
CoA
Producer
Produced in  India
|
Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested!
Certifications: coa
|
WC

All certificates

coa
WC
Producer
Produced in  Unknown
|
Audit Report: Click here for more information on Eurofins audit reports
Certifications: coa

All certificates

coa
Get full market intelligence report
Get full market intelligence report
€399,-
All Menthol data. Full access. Full negotiation power
Producer
Produced in  India
|
Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested!
Certifications: GMP
|
FDA
|
WC
|
coa

All certificates

GMP
FDA
WC
coa
Producer
Produced in  China
|
Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested!
Certifications: WC
|
CoA

All certificates

WC
CoA
Get full market intelligence report
Get full market intelligence report
€399,-
All Menthol data. Full access. Full negotiation power
Producer
Produced in  Germany
|
Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested!
Certifications: GMP
|
FDA
|
CEP
|
coa

All certificates

GMP
FDA
CEP
coa
Producer
Produced in  India
|
Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested!
Certifications: GMP
|
WC
|
CoA

All certificates

GMP
WC
CoA
Producer
Produced in  Japan
|
Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested!
Certifications: USDMF
|
CoA

All certificates

USDMF
CoA
Producer
Produced in  India
|
Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested!
Certifications: WC
|
CoA

All certificates

WC
CoA
Get full market intelligence report
Get full market intelligence report
€399,-
All Menthol data. Full access. Full negotiation power
Producer
Produced in  Unknown
|
Audit Report: Click here for more information on Eurofins audit reports
Certifications: GMP
|
FDA
|
CEP
|
USDMF
|
CoA

All certificates

GMP
FDA
CEP
USDMF
CoA
Not active
When insight is your advantage
Full data, full access, full negotiation power
Total market transparency Total market transparency
|
Supplier trade data access Supplier trade data access
|
Buyer / supplier flow comparison Buyer / supplier flow comparison
Trusted by 30,000+ registered pharma professionals:
Reach multinationals, SMEs, compounding pharmacies & more!
Procaps
Pfizer
Reckitt
Sanofi
Blau
Abbvie

Levomenthol | CAS No: 2216-51-5 | GMP-certified suppliers

A medication that provides temporary relief of minor throat irritation, cold-related cough, and mild oral or skin discomfort for over‑the‑counter symptomatic formulations.

Therapeutic categories

Agents causing hyperkalemiaAntiarrhythmic agentsAntipruriticsAntipruritics and Local AnestheticsBasic Lotions and LinimentsBradycardia-Causing Agents
Generic name
Levomenthol
Molecule type
small molecule
CAS number
2216-51-5
DrugBank ID
DB00825
Approval status
Approved drug

Primary indications

  • Used to treat occasional minor irritation, pain, sore mouth, and sore throat as well as cough associated with a cold or inhaled irritants

Product Snapshot

  • Levomenthol is supplied as a small-molecule ingredient formulated across topical, transdermal, oral, buccal, inhalation, and dental dosage forms
  • It is used for products addressing minor irritation, pain, sore mouth or throat, and cough associated with colds or inhaled irritants
  • It is approved for use in the United States and Canada

Clinical Overview

Levomenthol (CAS 2216-51-5) is the naturally occurring enantiomer of menthol, classified as a menthane monoterpenoid with the (1R,2S,5R) configuration. It occurs as a clear to white crystalline solid and is produced synthetically or derived from peppermint and other mint oils. Its sensory and mild anesthetic properties underpin its widespread use in oral, topical, and inhalation products.

Clinically, levomenthol is indicated for the temporary relief of minor throat irritation, cough associated with upper respiratory tract irritation, and mild oral or dermal discomfort. It is incorporated in over‑the‑counter lozenges, inhalation preparations, and topical formulations intended for symptomatic relief.

Pharmacologically, levomenthol induces a cooling sensation when applied to the skin or mucosa or when inhaled. This effect results from activation of TRPM8 cold-sensitive ion channels, producing a perception of coolness without an actual temperature change. Inhibition of neuronal calcium currents contributes to local anesthetic activity. Limited evidence suggests possible engagement of kappa‑opioid receptors, which may support mild analgesic effects, though this is not considered its primary mechanism.

Absorption after topical or oral exposure is variable and depends on formulation and route. Systemic exposure is generally low at typical over‑the‑counter doses. Levomenthol undergoes hepatic biotransformation, primarily through hydroxylation pathways, followed by conjugation and urinary excretion. Detailed quantitative ADME parameters are not well established.

Safety considerations mainly relate to local irritation at high concentrations, potential sensitization in susceptible individuals, and the risk of bronchospasm if excessive inhalation occurs. Systemic toxicity is uncommon at recommended doses. Use in children follows product‑specific restrictions due to the risk of respiratory sensitivity.

Common usage contexts include throat lozenges, cough drops, rubs, liniments, and inhalation aids. Levomenthol is also a flavor and fragrance component, but pharmaceutical applications require compliance with pharmacopeial purity standards.

For API procurement, sourcing should prioritize material meeting relevant pharmacopeial monographs, with attention to enantiomeric purity, residual solvent limits, and control of botanical impurities when plant-derived.

Identification & chemistry

Generic name Levomenthol
Molecule type Small molecule
CAS 2216-51-5
UNII BZ1R15MTK7
DrugBank ID DB00825

Pharmacology

SummaryMenthol activates TRPM8 receptors to produce a cooling sensation and modulates additional TRP channels and calcium flux, contributing to sensory effects on peripheral neurons. Its interaction with kappa‑opioid receptors may provide mild analgesic activity. These combined actions support its use for transient irritation, minor pain, and cough related to upper airway irritation.
Mechanism of actionMenthol primarily activates the cold-sensitive TRPM8 receptors in the skin. Menthol, after topical application, causes a feeling of coolness due to stimulation of 'cold' receptors by inhibiting Ca++ currents of neuronal membranes. It may also yield analgesic properties via kappa-opioid receptor agonism.
PharmacodynamicsMenthol is a covalent organic compound made synthetically or obtained from peppermint or other mint oils. Menthol induces a cooling sensation on the skin upon inhalation, oral ingestion, or topical application by stimulating the cold-sensitive receptors expressed on the skin, without actually causing a drop in the skin temperature.
Targets
TargetOrganismActions
Transient receptor potential cation channel subfamily M member 8Humansinducer
Transient receptor potential cation channel subfamily A member 1Humansinducer
Transient receptor potential cation channel subfamily V member 3Humansinducer

Formulation & handling

  • Levomenthol is a small, lipophilic monoterpenoid used primarily in topical, inhalation, transmucosal, and oral lozenge formulations, where its low aqueous solubility favors incorporation into oily bases or emulsified systems.
  • Its volatility and characteristic odor require controlled handling and tight containment during processing, with attention to evaporation losses in heated or open manufacturing steps.
  • For oral and buccal formats, solubility enhancement via solvents, surfactants, or melt-based systems is commonly needed to ensure uniform dispersion and consistent release.

Regulatory status

LifecycleThe API remains under patent protection in the US until 2027 and 2030, indicating that market exclusivity is still in place. With commercialization limited to the US and Canada, the product is in a mid‑lifecycle phase, with generic entry expected as patents expire.
MarketsUS, Canada
Supply Chain
Supply chain summaryLevomenthol is supplied by numerous packagers, indicating a fragmented manufacturing landscape without a single dominant originator company. Branded products are primarily present in the US and Canada across topical and liniment formulations. While levomenthol as an active substance is long established, certain US patents expiring between 2027 and 2030 may still affect specific protected formulations, with broader generic availability otherwise already established.

Safety

ToxicityMenthol, DL: ORAL (LD50): Acute: 2900 mg/kg [Rat], 3100 mg/kg [Mouse]. DERMAL (LD50): Acute: 5001 mg/kg [Rabbit].
High Level Warnings:
  • Moderate acute oral toxicity in rodents, with LD50 values around 2900–3100 mg/kg, indicating the need for controlled handling to limit ingestion exposure
  • Low dermal acute toxicity in rabbit studies (LD50 ›5000 mg/kg), though skin contact may still require routine industrial hygiene measures
  • Vapors and concentrated forms can act as local irritants, warranting appropriate containment to minimize inhalation and mucosal exposure

Menthol is a type of Herbal remedies


Herbal remedies, a subcategory of pharmaceutical active pharmaceutical ingredients (APIs), refer to medicinal products derived from plants. These remedies have been used for centuries in traditional medicine systems across various cultures worldwide. Herbal remedies harness the therapeutic properties of plant materials such as roots, leaves, flowers, and bark to treat a wide range of health conditions.

Herbal remedies are rich in bioactive compounds, including alkaloids, flavonoids, terpenes, and phenolic acids. These compounds exhibit diverse pharmacological activities and can provide benefits for various ailments. They may possess antioxidant, anti-inflammatory, antimicrobial, antiviral, or immunomodulatory properties, among others.

Pharmaceutical companies extensively research and develop herbal remedies to ensure their safety, efficacy, and standardization. The extraction and purification processes involve techniques such as solvent extraction, steam distillation, and chromatography. Quality control measures are implemented to maintain consistency and potency across batches.

Herbal remedies offer a natural alternative to conventional pharmaceutical drugs and are often preferred by individuals seeking holistic or complementary treatment options. They are commonly available in various forms, including capsules, tablets, tinctures, and topical formulations.

It is essential to note that while herbal remedies are generally considered safe, they can still have interactions with other medications and may not be suitable for everyone. Consulting with healthcare professionals or herbalists before starting any herbal treatment is recommended to ensure proper usage and avoid potential adverse effects.

Overall, herbal remedies within the pharmaceutical API subcategory provide a valuable option for individuals seeking natural alternatives and contribute to the growing field of plant-based medicine.


Menthol (Herbal remedies), classified under Others


The others category refers to pharmaceutical APIs that do not fall under specific classifications such as antibiotics, antivirals, analgesics, or cardiovascular drugs. These APIs are diverse in nature and serve various therapeutic purposes, making them a crucial component of pharmaceutical formulations.

Pharmaceutical companies develop APIs in the others category to address specific medical conditions or target novel biological pathways. This category includes APIs used in oncology, neurology, immunology, and other specialized areas of medicine. The APIs in this category are often designed to interact with specific molecular targets or receptors, providing targeted therapeutic effects.

The development of APIs in the others category requires extensive research and testing to ensure their efficacy, safety, and compliance with regulatory standards. Pharmaceutical manufacturers employ advanced techniques such as chemical synthesis, biotechnology, and genetic engineering to produce these APIs.

Due to the broad range of applications and therapeutic uses, APIs in the others category contribute significantly to the advancement of medical treatments. Pharmaceutical companies constantly strive to innovate and discover new APIs within this category to address unmet medical needs and improve patient outcomes.

In conclusion, the others category of pharmaceutical APIs encompasses a diverse range of active ingredients used in drug formulation. These APIs play a crucial role in developing innovative therapies across various therapeutic areas, contributing to advancements in healthcare and patient well-being.



Menthol API manufacturers & distributors

Compare qualified Menthol API suppliers worldwide. We currently have 13 companies offering Menthol API, with manufacturing taking place in 7 different countries. Use the table below to review supplier type, countries of origin, certifications, product portfolio and GMP audit availability.

SupplierTypeCountryProduct originCertificationsPortfolio
Producer
China China CoA, WC1 products
Producer
Germany Unknown CEP, CoA, FDA, GMP, USDMF18 products
Producer
India India CoA, GMP, WC1 products
Distributor
Germany France BSE/TSE, CoA, GMP, ISO9001, MSDS211 products
Distributor
Netherlands India CoA, GMP, ISO9001, MSDS170 products
Producer
Germany Unknown CoA5 products
Producer
India India CoA, FDA, GMP, WC27 products
Producer
Japan Japan CoA, USDMF2 products
Producer
India India CoA, WC2 products
Distributor
United States India BSE/TSE, CoA, GMP, MSDS, USDMF166 products
Distributor
United States United States BSE/TSE, CoA, GMP, ISO9001, MSDS144 products
Producer
India India CoA, WC1 products
Producer
Germany Germany CEP, CoA, FDA, GMP2 products

When sending a request, specify which Menthol API quality you need: for example EP (Ph. Eur.), USP, JP, BP, or another pharmacopoeial standard, as well as the required grade (base, salt, micronised, specific purity, etc.).

Use the list above to find high-quality Menthol API suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our help page to learn more about sourcing APIs via Pharmaoffer.

Frequently asked questions about Menthol API


Sourcing

What matters most when sourcing GMP-grade LevoMenthol?
Key considerations include confirming full GMP compliance and verifying that the supplier’s documentation meets US and Canadian regulatory expectations. In a fragmented supply landscape, consistent quality data, change‑control practices, and batch traceability are important to ensure uniformity across manufacturers. It is also essential to confirm that the intended use does not intersect with any still‑active US formulation patents expiring between 2027 and 2030.
Which documents are typically required when sourcing LevoMenthol API?
Request the core API documentation set: CoA (13 companies), GMP (8 companies), WC (5 companies), MSDS (4 companies), ISO9001 (3 companies). Confirm versions and validity dates match the destination market to avoid delays in qualification.
Which manufacturers are known to produce LevoMenthol API?
Known or reported manufacturers for LevoMenthol: Duchefa Farma B.V., Caesar & Loretz GmbH (CAELO), Pharm Rx Chemical Corp, Rochem International, Inc.. Evaluate their GMP history, scale, and regional coverage before requesting dossiers or allocating demand.
How can I request quotes for LevoMenthol API from GMP suppliers?
Submit quote requests through the supplier listings with your specs and required documents (specifications, target volume, delivery timeline, and destination). Providing consistent details upfront speeds comparable offers and clarifies technical feasibility.
Is a GMP audit report available for LevoMenthol manufacturers?
Audit reports may be requested for LevoMenthol: 3 GMP audit reports available. Confirm the scope and recency of any audit before relying on it for qualification decisions.
How many suppliers offer LevoMenthol API on Pharmaoffer?
Reported supplier count for LevoMenthol: 13 verified suppliers. Filter listings by certifications, regions, and delivery options to match your qualification plan.
Which countries are known to manufacture LevoMenthol API?
Production countries reported for LevoMenthol: India (6 producers), France (1 producer), United States (1 producer). Knowing the manufacturing geography helps anticipate logistics lead times and import compliance needs.
Which certifications do suppliers of LevoMenthol usually hold?
Common certifications for LevoMenthol suppliers: CoA (13 companies), GMP (8 companies), WC (5 companies), MSDS (4 companies), ISO9001 (3 companies). Always verify issuing authorities and expiry dates when reviewing audit packages.

Technical

What is LevoMenthol (CAS 2216-51-5) used for?
LevoMenthol is used for temporary relief of minor throat irritation, cough associated with upper respiratory tract irritation, and mild oral or dermal discomfort. Its cooling and mild anesthetic effects, produced through TRPM8 activation and calcium‑current inhibition, support its inclusion in lozenges, inhalation products, and topical formulations.
Which therapeutic class does LevoMenthol fall into?
LevoMenthol belongs to the following therapeutic categories: Agents causing hyperkalemia, Antiarrhythmic agents, Antipruritics, Antipruritics and Local Anesthetics, Basic Lotions and Liniments. This positioning helps teams compare alternative APIs, anticipate pharmacology expectations, and align early research priorities.
What conditions is LevoMenthol mainly prescribed for?
The primary indications for LevoMenthol: Used to treat occasional minor irritation, pain, sore mouth, and sore throat as well as cough associated with a cold or inhaled irritants. These use cases frame the target patient populations and help prioritize formulation and safety evaluations.
How does LevoMenthol work?
Menthol primarily activates the cold-sensitive TRPM8 receptors in the skin. Menthol, after topical application, causes a feeling of coolness due to stimulation of 'cold' receptors by inhibiting Ca++ currents of neuronal membranes. It may also yield analgesic properties via kappa-opioid receptor agonism.
What should someone know about the safety or toxicity profile of LevoMenthol?
LevoMenthol shows moderate acute oral toxicity in animal studies, so limiting ingestion beyond intended therapeutic use is important. Dermal toxicity is low, but concentrated material or vapors can cause local irritation, and routine protective measures help reduce skin and mucosal exposure. Systemic toxicity at recommended doses is uncommon, though sensitization or bronchospasm may occur in susceptible individuals or with excessive inhalation. Product‑specific precautions apply in children due to respiratory sensitivity.
What are important formulation and handling considerations for LevoMenthol as an API?
Important considerations include its low aqueous solubility, which often requires use of oily bases, emulsified systems, or solubility‑enhancing excipients to ensure uniform dispersion. Its volatility and strong odor necessitate controlled handling, tight containment, and minimization of open or heated processing steps to limit evaporation losses. Melt‑based or surfactant‑containing systems are commonly used in oral and buccal formats to achieve consistent release.
Is LevoMenthol a small molecule?
LevoMenthol is classified as a small molecule. That classification shapes process design, impurity profiling, and analytical control strategies.
Are there special stability concerns for oral LevoMenthol?
Yes. LevoMenthol is volatile, so oral formulations require measures to limit evaporation and loss of potency during processing and storage. Its low aqueous solubility can also lead to non‑uniform dispersion if not properly incorporated using suitable solvents, surfactants, or melt-based systems. Tight containment and controlled temperatures help maintain stability.

Regulatory

Where is LevoMenthol approved or in use globally?
LevoMenthol is reported as approved in the following major regions: US, Canada. Understanding geographic coverage informs regulatory filings, supply planning, and risk assessments before escalating procurement.
What’s the regulatory and patent landscape for LevoMenthol right now?
In the United States and Canada, LevoMenthol is an established ingredient regulated within standard pathways for therapeutic and consumer health products. Its patent landscape typically centers on specific formulations, delivery systems, or manufacturing processes rather than the substance itself.

Pharmaoffer

How does Pharmaoffer’s Smart Sourcing Service help with LevoMenthol procurement?
Pharmaoffer's Smart Sourcing Service coordinates compliant suppliers, documentation, and competitive quotes for LevoMenthol. It centralizes outreach, follow-ups, and document validation to shorten procurement timelines.
Is LevoMenthol included in the PRO Data Insights coverage?
PRO Data Insights coverage for LevoMenthol: 30404 verified transactions across 3393 suppliers and 2296 buyers worldwide. Use the dataset to benchmark suppliers and monitor regulatory activity where available.
Where can I access the API market report for LevoMenthol?
Market report availability for LevoMenthol: Report Available. The report highlights demand trends, pricing drivers, and supplier landscape insights for procurement planning.